2,2,3,3-Tetrafluoro-2,3-dihydro-1,4-benzodioxine, 98%, 2g

BAY 11-7085>97.0%(N)10mg

4-((4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)sulfonyl)morpholine, 98%, 5g

1,2-Dimethoxy-3-methylbenzene, 95.0%, 25g

(2E)-3-(furan-2-yl)-1-(2-methoxyphenyl)prop-2-en-1-one, 95.0%, 10g

[2-(3-benzyl-1,2,4-oxadiazol-5-yl)ethyl]amine hydrochloride, 95.0%, 1g

3-Fluorophenol, 99.0%, 10g

5-((tert-Butoxycarbonyl)amino)nicotinic acid, 95.0%, 10g

4,4,5,5-Tetramethyl-2-[10-(2-naphthyl)anthracen-9-yl]-1,3,2-dioxaborolane>97.0%(GC)1g

2,6-Di-tert-butylpyridine, 95.0%, 25g

2-(tert-Butoxycarbonyl)-2-azaspiro[3.3]heptane-5-carboxylic acid, 98%, 500mg

Ethyl 3-methyl-2-nitrobenzoate, 95.0%, 10g

4-Chloro-3-hydroxybenzyl alcohol, 96%, 1g